Actemra 160mg, a drug known scientifically as tocilizumab, represents a potent pharmaceutical agent primarily employed for the management of rheumatoid arthritis. This effective agent functions by interfering with the activity of interleukin-6 (IL-6), a signaling protein vital in the inflammatory process. Moreover, Actemra demonstrates efficacy in